Human Genome Epidemiology Literature Finder
Records 1 - 17 (of 17 Records) |
Query Trace: Breast Neoplasms and CYP17A1[original query] |
---|
Functional maternal catechol-O-methyltransferase polymorphism and fetal growth restriction. Pharmacogenetics and genomics 2006 Nov 16 (11): 775-81. Sata Fumihiro, Yamada Hideto, Suzuki Kana, Saijo Yasuaki, Yamada Takashi, Minakami Hisanori, Kishi Rei |
Breast cancer: a candidate gene approach across the estrogen metabolic pathway. Breast Cancer Res Treat 2007 Jun . Justenhoven C, Hamann U, Schubert F, Zapatka M, Pierl CB, Rabstein S, Selinski S, Mueller T, Ickstadt K, Gilbert M, Ko YD, Baisch C, Pesch B, Harth V, Bolt HM, Vollmert C, Illig T, Eils R, Dippon J, Brauch H |
Possible difference in frequencies of genetic polymorphisms of estrogen receptor alpha, estrogen metabolism and P53 genes between estrogen receptor-positive and -negative breast cancers. Japanese journal of clinical oncology 2008 Nov 38 (11): 734-42. Hamaguchi Maho, Nishio Mariko, Toyama Tatsuya, Sugiura Hiroshi, Kondo Naoto, Fujii Yoshitaka, Yamashita Hiro |
Polymorphisms in steroid hormone biosynthesis genes and risk of breast cancer and fibrocystic breast conditions in Chinese women. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 May 17 (5): 1066-73. Sakoda Lori C, Blackston Christie, Doherty Jennifer A, Ray Roberta M, Lin Ming Gang, Stalsberg Helge, Gao Dao Li, Feng Ziding, Thomas David B, Chen C |
The CYP17A1 -34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast cancer research and treatment 2011 Apr 126 (2): 521-7. Kaufman Bella, Laitman Yael, Ziv Elad, Hamann Ute, Torres Diana, Lahad Ephrat Levy, Beeri Rachel, Renbaum Paul, Jakubowska Anna, Lubinski Jan, Huzarski Tomasz, To?oczko-Grabarek Aleksandra, Jaworska Katarzyna, Durda Katarzyna, Sprudle Amanda B, Chenevix-Trench Georgia, Simard Jacques, Easton Douglas F, Antonis Antoniou, Szabo Csilla, Friedman Eit |
Estrogen-related genes and their contribution to racial differences in breast cancer risk. Cancer causes & control : CCC 2012 May 23 (5): 671-81. Reding Kerryn W, Chen Chu, Lowe Kimberly, Doody David R, Carlson Christopher S, Chen Christina T, Houck John, Weiss Linda K, Marchbanks Polly A, Bernstein Leslie, Spirtas Robert, McDonald Jill A, Strom Brian L, Burkman Ronald T, Simon Michael S, Liff Jonathan M, Daling Janet R, Malone Kathleen |
Genetic determinants of aromatase inhibitor-related arthralgia: the B-ABLE cohort study. Breast cancer research and treatment 2013 Jul 140 (2): 385-95. Garcia-Giralt Natalia, Rodríguez-Sanz María, Prieto-Alhambra Daniel, Servitja Sonia, Torres-Del Pliego Elisa, Balcells Susana, Albanell Joan, Grinberg Daniel, Diez-Perez Adolfo, Tusquets Ignasi, Nogués Xavi |
Polymorphisms in phase I and phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case-control study in Inuit women. Environmental health : a global access science source 2014 13 (1): 19. Ghisari Mandana, Eiberg Hans, Long Manhai, Bonefeld-Jørgensen Eva |
Genetic polymorphisms of ESR1, ESR2, CYP17A1, and CYP19A1 and the risk of breast cancer: a case control study from North India. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 May 35 (5): 4517-27. Chattopadhyay Shilpi, Siddiqui Sarah, Akhtar Md Salman, Najm Mohammad Zeeshan, Deo S V S, Shukla N K, Husain Syed Akht |
CYP11A1 expression in bone is associated with aromatase inhibitor-related bone loss. Journal of molecular endocrinology 2015 Aug 55 (1): 69-79. Rodríguez-Sanz M, García-Giralt N, Prieto-Alhambra D, Servitja S, Balcells S, Pecorelli R, Díez-Pérez A, Grinberg D, Tusquets I, Nogués |
Pharmacogenetics and aromatase inhibitor induced side effects in breast cancer patients. Pharmacogenomics 2017 Jun . Sini Valentina, Botticelli Andrea, Lunardi Gianluigi, Gori Stefania, Marchetti Pao |
Polymorphism in xenobiotic and estrogen metabolizing genes, exposure to perfluorinated compounds and subsequent breast cancer risk: A nested case-control study in the Danish National Birth Cohort. Environmental research 2017 Jan 154 325-333. Ghisari Mandana, Long Manhai, Røge Durita Mohr, Olsen Jørn, Bonefeld-Jørgensen Eva |
Genetic Variations, Exposure to Persistent Organic Pollutants and Breast Cancer Risk - A Greenlandic Case-Control Study. Basic & clinical pharmacology & toxicology 2018 Mar . Wielsøe Maria, Eiberg Hans, Ghisari Mandana, Kern Peder, Lind Ole, Bonefeld-Jørgensen Eva Cecil |
Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer risk. Endocrine connections 2019 Jul . Rizzolo Piera, Silvestri Valentina, Valentini Virginia, Zelli Veronica, Bucalo Agostino, Zanna Ines, Bianchi Simonetta, Tibiletti Maria Grazia, Russo Antonio, Varesco Liliana, Tedaldi Gianluca, Bonanni Bernardo, Azzollini Jacopo, Manoukian Siranoush, Coppa Anna, Giannini Giuseppe, Cortesi Laura, Viel Alessandra, Montagna Marco, Peterlongo Paolo, Radice Paolo, Palli Domenico, Ottini Lau |
Urinary bisphenol A and its interaction with CYP17A1 rs743572 are associated with breast cancer risk. Chemosphere 2021 Aug 286 (Pt 3): 131880. He Heng, Deng Yao, Wan Hao, Shen Na, Li Jiaoyuan, Zeng Qiang, Chang Jiang, Lu Qing, Miao Xiaoping, Tian Jianbo, Zhong Ro |
Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer. Frontiers in genetics 2021 12 662734. Hertz Daniel L, Smith Karen Lisa, Zong Yuhua, Gersch Christina L, Pesch Andrea M, Lehman Jennifer, Blackford Amanda L, Henry N Lynn, Kidwell Kelley M, Rae James M, Stearns Ver |
Variable expression quantitative trait loci analysis of breast cancer risk variants. Scientific reports 2021 3 11 (1): 7192. Wiggins George A R, Black Michael A, Dunbier Anita, Merriman Tony R, Pearson John F, Walker Logan |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: